Rightslink® by Copyright Clearance Center

Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial

Author:

Silvia Novello,David R. Spigel,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Alejandro Navarro,Eva Lotte Buchmeier,John Wen-Cheng Chang,Yoshimasa Shiraishi,Mustafa Özgüroğlu,Yu Jung Kim,Nguyen Thi Thai Hoa,Sayed M.S. Hashemi,Anne C. Chiang et al.

Publication:

Journal of Thoracic Oncology

Publisher:

Elsevier

Date:

June 2026

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the Creative Commons CC-BY-NC-ND license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.